Elevated RNASEK levels were linked to good prognosis in LAML, BLCA, CESC, KIRP, OV, and PAAD, but poor prognosis in ESCA, HNSC, KICH, KIRP, and READ patients. The gene discussed is RNASEK; the disease is pancreatic adenocarcinoma.